OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Psychedelic Harm Reduction and Integration: A Transtheoretical Model for Clinical Practice
Ingmar Gorman, Elizabeth M. Nielson, Aja Molinar, et al.
Frontiers in Psychology (2021) Vol. 12
Open Access | Times Cited: 75

Showing 1-25 of 75 citing articles:

Adverse effects of psychedelics: From anecdotes and misinformation to systematic science
Anne Katrin Schlag, Jacob S. Aday, Iram Salam, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 3, pp. 258-272
Open Access | Times Cited: 219

Extended difficulties following the use of psychedelic drugs: A mixed methods study
Jules Evans, Oliver Robinson, Eirini K. Argyri, et al.
PLoS ONE (2023) Vol. 18, Iss. 10, pp. e0293349-e0293349
Open Access | Times Cited: 58

Case analysis of long-term negative psychological responses to psychedelics
Rebecka Bremler, Nancy Katati, Parvinder Shergill, et al.
Scientific Reports (2023) Vol. 13, Iss. 1
Open Access | Times Cited: 41

The Psychedelic Future of Post-Traumatic Stress Disorder Treatment
Tamar Glatman Zaretsky, Kathleen M. Jagodnik, Robert Barsic, et al.
Current Neuropharmacology (2024) Vol. 22, Iss. 4, pp. 636-735
Open Access | Times Cited: 15

Psychiatric risks for worsened mental health after psychedelic use
Alessia Marrocu, Hannes Kettner, Brandon Weiss, et al.
Journal of Psychopharmacology (2024) Vol. 38, Iss. 3, pp. 225-235
Open Access | Times Cited: 15

Psychedelic integration: An analysis of the concept and its practice
Geoff J. Bathje, Eric Majeski, Mesphina Kudowor
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 63

Risks and benefits of psilocybin use in people with bipolar disorder: An international web-based survey on experiences of ‘magic mushroom’ consumption
Emma Morton, Kimberly Sakai, Amir Ashtari, et al.
Journal of Psychopharmacology (2022) Vol. 37, Iss. 1, pp. 49-60
Open Access | Times Cited: 44

Adverse experiences resulting in emergency medical treatment seeking following the use of magic mushrooms
Emma I Kopra, Jason Ferris, Adam Winstock, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 8, pp. 965-973
Open Access | Times Cited: 43

The Acceptance/Avoidance-Promoting Experiences Questionnaire (APEQ): A theory-based approach to psychedelic drugs’ effects on psychological flexibility
Max Wolff, Lea J. Mertens, Marie Walter, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 3, pp. 387-408
Open Access | Times Cited: 37

Investigation of self-treatment with lysergic acid diethylamide and psilocybin mushrooms: Findings from the Global Drug Survey 2020
Emma I Kopra, Jason Ferris, Adam Winstock, et al.
Journal of Psychopharmacology (2023) Vol. 37, Iss. 7, pp. 733-748
Open Access | Times Cited: 32

The psychedelic afterglow phenomenon: a systematic review of subacute effects of classic serotonergic psychedelics
Ricarda Evens, Marianna E. Schmidt, Tomislav Majić, et al.
Therapeutic Advances in Psychopharmacology (2023) Vol. 13
Open Access | Times Cited: 23

On the need for metaphysics in psychedelic therapy and research
Peter Sjöstedt-Hughes
Frontiers in Psychology (2023) Vol. 14
Open Access | Times Cited: 22

Top Ten Tips Palliative Care Clinicians Should Know About Psychedelic-Assisted Therapy in the Context of Serious Illness
William E. Rosa, Zachary Sager, Megan E. Miller, et al.
Journal of Palliative Medicine (2022) Vol. 25, Iss. 8, pp. 1273-1281
Open Access | Times Cited: 35

Counselors’ attitudes toward psychedelics and their use in therapy
Benjamin Hearn, Michael D. Brubaker, George B. Richardson
Journal of Counseling & Development (2022) Vol. 100, Iss. 4, pp. 364-373
Open Access | Times Cited: 31

Adverse experiences resulting in emergency medical treatment seeking following the use of lysergic acid diethylamide (LSD)
Emma I Kopra, Jason Ferris, James Rucker, et al.
Journal of Psychopharmacology (2022) Vol. 36, Iss. 8, pp. 956-964
Open Access | Times Cited: 31

Navigating Groundlessness: An interview study on dealing with ontological shock and existential distress following psychedelic experiences
Eirini K. Argyri, Jules Evans, David Luke, et al.
SSRN Electronic Journal (2024)
Closed Access | Times Cited: 6

A Transformative Trip? Experiences of Psychedelic Use
Logan Neitzke‐Spruill, Caroline Beit, Jill O. Robinson, et al.
Neuroethics (2024) Vol. 17, Iss. 2
Open Access | Times Cited: 5

Impact of psilocybin on cognitive function: A systematic review
Shakila Meshkat, Triana Juliana Tello‐Gerez, Fatemeh Gholaminezhad, et al.
Psychiatry and Clinical Neurosciences (2024) Vol. 78, Iss. 12, pp. 744-764
Open Access | Times Cited: 5

Social Worker Attitudes towards Psychedelics
Eva Nowakowski-Sims, Joshua Holzworth
Clinical Social Work Journal (2025)
Open Access

Shame, Guilt and Psychedelic Experience: Results from a Prospective, Longitudinal Survey of Real-World Psilocybin Use
David S. Mathai, Daniel E. Roberts, Sandeep M. Nayak, et al.
Journal of Psychoactive Drugs (2025), pp. 1-12
Open Access

Societal Trends and Opportunities in the Aftermath of the Nova Psychedelic Trance Rave, Through Lilla and Benjamin
Demian Halperin, Tal Bar On, Nir Tadmor, et al.
Future Humanities (2025) Vol. 3, Iss. 1
Open Access

Psilocybin-Assisted Compassion Focused Therapy for Depression
Wendy Pots, Farid Chakhssi
Frontiers in Psychology (2022) Vol. 13
Open Access | Times Cited: 22

Page 1 - Next Page

Scroll to top